Skip to main content
Log in

Migraine: naratriptan dominant over conventional care

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Migraine: naratriptan dominant over conventional care. Pharmacoecon. Outcomes News 321, 6 (2001). https://doi.org/10.1007/BF03269466

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03269466

Keywords

Navigation